Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
Supporting obesity and metabolic health with a USD 5 million contribution from Boehringer Ingelheim over three years Collaboration will strengthen integrated care for obesity and related cardiovascular, kidney, liver and metabolic diseases to improve outcomes for people worldwide living with these interconnected diseases Ingelheim, Germany – Boehringer Ingelheim and the WHO Foundation today announced a […]
\